ID   CP2J2_HUMAN             Reviewed;         502 AA.
AC   P51589; B2RD33; Q8TF13;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   27-MAY-2002, sequence version 2.
DT   10-MAY-2017, entry version 166.
DE   RecName: Full=Cytochrome P450 2J2;
DE            EC=1.14.14.1;
DE   AltName: Full=Arachidonic acid epoxygenase;
DE   AltName: Full=CYPIIJ2;
GN   Name=CYP2J2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 1-20.
RC   TISSUE=Liver;
RX   PubMed=8631948; DOI=10.1074/jbc.271.7.3460;
RA   Wu S., Moomaw C.R., Tomer K.B., Falck J.R., Zeldin D.C.;
RT   "Molecular cloning and expression of CYP2J2, a human cytochrome P450
RT   arachidonic acid epoxygenase highly expressed in heart.";
RL   J. Biol. Chem. 271:3460-3468(1996).
RN   [2]
RP   SEQUENCE REVISION TO 339 AND 378.
RA   Wu S., Zeldin D.C., Moomaw C.R., Tomer K.B., Falck J.R.;
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=12386130; DOI=10.1124/dmd.30.11.1240;
RA   Matsumoto S., Hirama T., Matsubara T., Nagata K., Yamazoe Y.;
RT   "Involvement of CYP2J2 on the intestinal first-pass metabolism of
RT   antihistamine drug, astemizole.";
RL   Drug Metab. Dispos. 30:1240-1245(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS ALA-143; CYS-158; ASN-192;
RP   ASN-342 AND TYR-404, AND CHARACTERIZATION OF VARIANTS.
RX   PubMed=11901223; DOI=10.1124/mol.61.4.840;
RA   King L.M., Ma J., Srettabunjong S., Graves J., Bradbury J.A., Li L.,
RA   Spiecker M., Liao J.K., Mohrenweiser H., Zeldin D.C.;
RT   "Cloning of CYP2J2 gene and identification of functional
RT   polymorphisms.";
RL   Mol. Pharmacol. 61:840-852(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-49.
RG   NIEHS SNPs program;
RL   Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Corpus callosum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: This enzyme metabolizes arachidonic acid predominantly
CC       via a NADPH-dependent olefin epoxidation to all four regioisomeric
CC       cis-epoxyeicosatrienoic acids. One of the predominant enzymes
CC       responsible for the epoxidation of endogenous cardiac arachidonic
CC       acid pools.
CC   -!- CATALYTIC ACTIVITY: RH + [reduced NADPH--hemoprotein reductase] +
CC       O(2) = ROH + [oxidized NADPH--hemoprotein reductase] + H(2)O.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000250};
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral
CC       membrane protein. Microsome membrane; Peripheral membrane protein.
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart, present at lower
CC       levels in liver, ileum, jejunum, colon, and kidney.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Cytochrome P450 Allele Nomenclature Committee;
CC       Note=CYP2J2 alleles;
CC       URL="http://www.cypalleles.ki.se/cyp2j2.htm";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/cyp2j2/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U37143; AAC50370.2; -; mRNA.
DR   EMBL; AB080265; BAB85489.1; -; mRNA.
DR   EMBL; AF272142; AAM44456.1; -; Genomic_DNA.
DR   EMBL; AY426985; AAQ93356.1; -; Genomic_DNA.
DR   EMBL; AK315387; BAG37780.1; -; mRNA.
DR   EMBL; BC032594; AAH32594.1; -; mRNA.
DR   CCDS; CCDS613.1; -.
DR   RefSeq; NP_000766.2; NM_000775.3.
DR   UniGene; Hs.152096; -.
DR   ProteinModelPortal; P51589; -.
DR   SMR; P51589; -.
DR   BioGrid; 107946; 3.
DR   IntAct; P51589; 2.
DR   STRING; 9606.ENSP00000360247; -.
DR   BindingDB; P51589; -.
DR   ChEMBL; CHEMBL3491; -.
DR   DrugBank; DB06605; Apixaban.
DR   DrugBank; DB00637; Astemizole.
DR   DrugBank; DB00169; Cholecalciferol.
DR   DrugBank; DB09148; Florbetaben (18F).
DR   DrugBank; DB08918; Levomilnacipran.
DR   DrugBank; DB04725; Licofelone.
DR   DrugBank; DB00179; Masoprocol.
DR   DrugBank; DB08931; Riociguat.
DR   DrugBank; DB06228; Rivaroxaban.
DR   DrugBank; DB00342; Terfenadine.
DR   GuidetoPHARMACOLOGY; 1332; -.
DR   SwissLipids; SLP:000001594; -.
DR   iPTMnet; P51589; -.
DR   PhosphoSitePlus; P51589; -.
DR   BioMuta; CYP2J2; -.
DR   DMDM; 21264413; -.
DR   EPD; P51589; -.
DR   MaxQB; P51589; -.
DR   PaxDb; P51589; -.
DR   PeptideAtlas; P51589; -.
DR   PRIDE; P51589; -.
DR   DNASU; 1573; -.
DR   Ensembl; ENST00000371204; ENSP00000360247; ENSG00000134716.
DR   GeneID; 1573; -.
DR   KEGG; hsa:1573; -.
DR   UCSC; uc001czq.4; human.
DR   CTD; 1573; -.
DR   DisGeNET; 1573; -.
DR   GeneCards; CYP2J2; -.
DR   HGNC; HGNC:2634; CYP2J2.
DR   MIM; 601258; gene.
DR   neXtProt; NX_P51589; -.
DR   OpenTargets; ENSG00000134716; -.
DR   PharmGKB; PA27112; -.
DR   eggNOG; KOG0156; Eukaryota.
DR   eggNOG; COG2124; LUCA.
DR   GeneTree; ENSGT00760000118775; -.
DR   HOGENOM; HOG000036991; -.
DR   HOVERGEN; HBG015789; -.
DR   InParanoid; P51589; -.
DR   KO; K07418; -.
DR   OMA; MSKHTGN; -.
DR   OrthoDB; EOG091G0BT8; -.
DR   PhylomeDB; P51589; -.
DR   TreeFam; TF352043; -.
DR   BRENDA; 1.14.13.159; 2681.
DR   Reactome; R-HSA-211935; Fatty acids.
DR   Reactome; R-HSA-211981; Xenobiotics.
DR   Reactome; R-HSA-2142670; Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET).
DR   GeneWiki; CYP2J2; -.
DR   GenomeRNAi; 1573; -.
DR   PRO; PR:P51589; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000134716; -.
DR   CleanEx; HS_CYP2J2; -.
DR   Genevisible; P51589; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0031090; C:organelle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008405; F:arachidonic acid 11,12-epoxygenase activity; IDA:BHF-UCL.
DR   GO; GO:0008404; F:arachidonic acid 14,15-epoxygenase activity; IDA:BHF-UCL.
DR   GO; GO:0008392; F:arachidonic acid epoxygenase activity; IDA:BHF-UCL.
DR   GO; GO:0070330; F:aromatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0071614; F:linoleic acid epoxygenase activity; IDA:BHF-UCL.
DR   GO; GO:0004497; F:monooxygenase activity; TAS:Reactome.
DR   GO; GO:0019373; P:epoxygenase P450 pathway; IDA:BHF-UCL.
DR   GO; GO:0006690; P:icosanoid metabolic process; TAS:ProtInc.
DR   GO; GO:0043651; P:linoleic acid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0008016; P:regulation of heart contraction; TAS:ProtInc.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:BHF-UCL.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002401; Cyt_P450_E_grp-I.
DR   InterPro; IPR008071; Cyt_P450_E_grp-I_CYP2J-like.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00463; EP450I.
DR   PRINTS; PR01688; EP450ICYP2J.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; SSF48264; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Direct protein sequencing; Endoplasmic reticulum;
KW   Heme; Iron; Membrane; Metal-binding; Microsome; Monooxygenase; NADP;
KW   Oxidoreductase; Polymorphism; Reference proteome.
FT   CHAIN         1    502       Cytochrome P450 2J2.
FT                                /FTId=PRO_0000051769.
FT   METAL       448    448       Iron (heme axial ligand). {ECO:0000250}.
FT   VARIANT      49     49       R -> S (in dbSNP:rs11572190).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_029159.
FT   VARIANT     113    113       V -> M (in dbSNP:rs11572242).
FT                                /FTId=VAR_029160.
FT   VARIANT     124    124       N -> S (in dbSNP:rs2228113).
FT                                /FTId=VAR_022084.
FT   VARIANT     143    143       T -> A (in allele CYP2J2*2; significantly
FT                                reduced metabolism of both arachidonic
FT                                acid and linoleic acid;
FT                                dbSNP:rs55753213).
FT                                {ECO:0000269|PubMed:11901223}.
FT                                /FTId=VAR_014317.
FT   VARIANT     158    158       R -> C (in allele CYP2J2*3; significantly
FT                                reduced metabolism of both arachidonic
FT                                acid and linoleic acid;
FT                                dbSNP:rs56307989).
FT                                {ECO:0000269|PubMed:11901223}.
FT                                /FTId=VAR_014318.
FT   VARIANT     192    192       I -> N (in allele CYP2J2*4; significantly
FT                                reduced metabolism of arachidonic acid
FT                                only; dbSNP:rs66515830).
FT                                {ECO:0000269|PubMed:11901223}.
FT                                /FTId=VAR_014319.
FT   VARIANT     342    342       D -> N (in allele CYP2J2*5; no change in
FT                                activity; dbSNP:rs56053398).
FT                                {ECO:0000269|PubMed:11901223}.
FT                                /FTId=VAR_014320.
FT   VARIANT     404    404       N -> Y (in allele CYP2J2*6; significantly
FT                                reduced metabolism of both arachidonic
FT                                acid and linoleic acid;
FT                                dbSNP:rs72547598).
FT                                {ECO:0000269|PubMed:11901223}.
FT                                /FTId=VAR_014321.
FT   CONFLICT    264    264       K -> E (in Ref. 6; BAG37780).
FT                                {ECO:0000305}.
FT   CONFLICT    318    318       T -> A (in Ref. 6; BAG37780).
FT                                {ECO:0000305}.
FT   CONFLICT    339    339       A -> V (in Ref. 3; BAB85489).
FT                                {ECO:0000305}.
SQ   SEQUENCE   502 AA;  57611 MW;  B5F006581E249EC0 CRC64;
     MLAAMGSLAA ALWAVVHPRT LLLGTVAFLL AADFLKRRRP KNYPPGPWRL PFLGNFFLVD
     FEQSHLEVQL FVKKYGNLFS LELGDISAVL ITGLPLIKEA LIHMDQNFGN RPVTPMREHI
     FKKNGLIMSS GQAWKEQRRF TLTALRNFGL GKKSLEERIQ EEAQHLTEAI KEENGQPFDP
     HFKINNAVSN IICSITFGER FEYQDSWFQQ LLKLLDEVTY LEASKTCQLY NVFPWIMKFL
     PGPHQTLFSN WKKLKLFVSH MIDKHRKDWN PAETRDFIDA YLKEMSKHTG NPTSSFHEEN
     LICSTLDLFF AGTETTSTTL RWALLYMALY PEIQEKVQAE IDRVIGQGQQ PSTAARESMP
     YTNAVIHEVQ RMGNIIPLNV PREVTVDTTL AGYHLPKGTM ILTNLTALHR DPTEWATPDT
     FNPDHFLENG QFKKREAFMP FSIGKRACLG EQLARTELFI FFTSLMQKFT FRPPNNEKLS
     LKFRMGITIS PVSHRLCAVP QV
//
